Individual patient risk assessment and cost-benefit analysis of patiromer in AMBER - Authors' reply. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(20)30534-1
PubMed Identifier: 32738950
Publication URI: http://europepmc.org/abstract/MED/32738950
Type: Journal Article/Review
Volume: 396
Parent Publication: Lancet (London, England)
Issue: 10247
ISSN: 0140-6736